Novabay Pharmaceuticals Stock Price History

NBY Stock  USD 0.07  0.01  12.01%   
If you're considering investing in NovaBay Stock, it is important to understand the factors that can impact its price. As of today, the current price of NovaBay Pharmaceuticals stands at 0.07, as last reported on the 23rd of April, with the highest price reaching 0.09 and the lowest price hitting 0.07 during the day. NovaBay Pharmaceuticals has Sharpe Ratio of -0.16, which conveys that the firm had a -0.16% return per unit of risk over the last 3 months. NovaBay Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NovaBay Pharmaceuticals' Risk Adjusted Performance of (0.09), standard deviation of 5.98, and Mean Deviation of 4.32 to check out the risk estimate we provide.
  
NovaBay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1611

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNBY

Estimated Market Risk

 5.98
  actual daily
52
52% of assets are less volatile

Expected Return

 -0.96
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.16
  actual daily
0
Most of other assets perform better
Based on monthly moving average NovaBay Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NovaBay Pharmaceuticals by adding NovaBay Pharmaceuticals to a well-diversified portfolio.

NovaBay Pharmaceuticals Stock Price History Chart

There are several ways to analyze NovaBay Stock price data. The simplest method is using a basic NovaBay candlestick price chart, which shows NovaBay Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 29, 20240.18
Lowest PriceApril 22, 20240.0725

NovaBay Pharmaceuticals April 23, 2024 Stock Price Synopsis

Various analyses of NovaBay Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell NovaBay Stock. It can be used to describe the percentage change in the price of NovaBay Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of NovaBay Stock.
NovaBay Pharmaceuticals Price Daily Balance Of Power(0.47)
NovaBay Pharmaceuticals Price Rate Of Daily Change 0.88 
NovaBay Pharmaceuticals Price Action Indicator(0.01)

NovaBay Pharmaceuticals April 23, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in NovaBay Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use NovaBay Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in NovaBay Stock and then apply it to test your longer-term investment strategies against NovaBay.

NovaBay Stock Price History Data

The price series of NovaBay Pharmaceuticals for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.11 with a coefficient of variation of 21.29. The daily prices for the period are spread out with arithmetic mean of 0.13. The median price for the last 90 days is 0.14. The company underwent 1:35 stock split on 16th of November 2022.
OpenHighLowCloseVolume
04/23/2024
 0.08  0.09  0.07  0.07 
04/22/2024 0.08  0.09  0.07  0.07  4,146,227 
04/19/2024 0.08  0.09  0.08  0.08  1,663,539 
04/18/2024 0.08  0.09  0.08  0.08  3,532,078 
04/17/2024 0.10  0.10  0.08  0.08  13,566,712 
04/16/2024 0.08  0.08  0.07  0.08  1,850,525 
04/15/2024 0.09  0.09  0.08  0.08  1,667,907 
04/12/2024 0.08  0.09  0.08  0.09  691,280 
04/11/2024 0.09  0.09  0.09  0.09  1,350,011 
04/10/2024 0.09  0.09  0.09  0.09  1,214,778 
04/09/2024 0.1  0.1  0.08  0.09  2,268,941 
04/08/2024 0.1  0.10  0.09  0.09  2,001,955 
04/05/2024 0.11  0.11  0.1  0.10  1,871,980 
04/04/2024 0.10  0.11  0.10  0.10  2,088,011 
04/03/2024 0.10  0.10  0.10  0.10  1,913,583 
04/02/2024 0.11  0.11  0.10  0.10  1,490,235 
04/01/2024 0.11  0.11  0.10  0.10  1,157,782 
03/29/2024 0.11  0.11  0.10  0.10  2,093,033 
03/28/2024 0.11  0.11  0.10  0.10  2,093,033 
03/27/2024 0.13  0.13  0.10  0.11  7,792,487 
03/26/2024 0.13  0.15  0.13  0.14  11,711,927 
03/25/2024 0.13  0.14  0.13  0.13  2,007,864 
03/22/2024 0.14  0.14  0.13  0.14  484,028 
03/21/2024 0.14  0.14  0.14  0.14  1,012,179 
03/20/2024 0.14  0.14  0.14  0.14  671,188 
03/19/2024 0.14  0.14  0.14  0.14  596,495 
03/18/2024 0.14  0.14  0.14  0.14  997,686 
03/15/2024 0.13  0.14  0.13  0.14  1,004,435 
03/14/2024 0.15  0.15  0.13  0.13  12,426,404 
03/13/2024 0.14  0.15  0.14  0.14  1,053,530 
03/12/2024 0.14  0.14  0.14  0.14  767,604 
03/11/2024 0.14  0.14  0.14  0.14  703,756 
03/08/2024 0.15  0.15  0.14  0.14  733,220 
03/07/2024 0.14  0.14  0.14  0.14  1,002,154 
03/06/2024 0.15  0.15  0.14  0.14  1,594,969 
03/05/2024 0.15  0.16  0.15  0.15  1,434,149 
03/04/2024 0.16  0.16  0.15  0.15  1,427,406 
03/01/2024 0.15  0.15  0.15  0.15  1,091,944 
02/29/2024 0.15  0.15  0.14  0.15  1,346,336 
02/28/2024 0.14  0.16  0.14  0.15  1,788,079 
02/27/2024 0.15  0.15  0.14  0.14  1,656,173 
02/26/2024 0.15  0.16  0.14  0.15  1,537,438 
02/23/2024 0.15  0.16  0.15  0.15  1,194,575 
02/22/2024 0.15  0.15  0.14  0.15  1,544,465 
02/21/2024 0.16  0.16  0.15  0.15  1,743,322 
02/20/2024 0.17  0.17  0.15  0.16  1,988,537 
02/16/2024 0.16  0.17  0.15  0.17  3,152,463 
02/15/2024 0.15  0.16  0.14  0.16  3,455,571 
02/14/2024 0.14  0.16  0.14  0.15  2,146,358 
02/13/2024 0.14  0.14  0.13  0.14  896,287 
02/12/2024 0.15  0.15  0.14  0.14  2,333,755 
02/09/2024 0.14  0.16  0.14  0.15  3,542,134 
02/08/2024 0.13  0.14  0.13  0.14  2,231,049 
02/07/2024 0.13  0.13  0.12  0.13  2,897,355 
02/06/2024 0.15  0.15  0.13  0.13  4,391,447 
02/05/2024 0.16  0.16  0.15  0.15  3,798,946 
02/02/2024 0.16  0.16  0.15  0.16  3,121,184 
02/01/2024 0.18  0.18  0.16  0.16  9,327,061 
01/31/2024 0.16  0.19  0.15  0.17  15,503,852 
01/30/2024 0.17  0.18  0.16  0.16  8,698,162 
01/29/2024 0.19  0.20  0.16  0.18  42,337,445 

About NovaBay Pharmaceuticals Stock history

NovaBay Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NovaBay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NovaBay Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NovaBay Pharmaceuticals stock prices may prove useful in developing a viable investing in NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. Novabay Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 29 people.

NovaBay Pharmaceuticals Stock Technical Analysis

NovaBay Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of NovaBay Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NovaBay Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

NovaBay Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NovaBay Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of NovaBay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NovaBay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether NovaBay Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NovaBay Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novabay Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novabay Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NovaBay Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for NovaBay Stock analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Transaction History
View history of all your transactions and understand their impact on performance
Is NovaBay Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NovaBay Pharmaceuticals. If investors know NovaBay will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NovaBay Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of NovaBay Pharmaceuticals is measured differently than its book value, which is the value of NovaBay that is recorded on the company's balance sheet. Investors also form their own opinion of NovaBay Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is NovaBay Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NovaBay Pharmaceuticals' market value can be influenced by many factors that don't directly affect NovaBay Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NovaBay Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if NovaBay Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NovaBay Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.